PMGC Holdings (ELAB) Times Interest Earned (2022 - 2026)
PMGC Holdings (ELAB) posted Times Interest Earned of -$1.19 for Q1 2026, up 88.25% sequentially from -$10.15 in Q4 2025, and down 110.24% YoY from $11.63 in Q1 2025.
PMGC Holdings (ELAB) Times Interest Earned (2022 - 2026) Analysis & Trends
PMGC Holdings has reported Times Interest Earned for 5 years, with the latest figure at -$1.19 in Q1 2026.
- Quarterly Times Interest Earned fell 110.24% year-over-year to -$1.19 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.86 (up 51.01% YoY) and the FY2025 annual result came in at -$6.7, down 1093.28% from the prior year.
- Times Interest Earned rose to -$1.19 in Q1 2026 per ELAB's latest filing, from -$10.15 in the prior quarter.
- Over five years, Times Interest Earned peaked at $11.63 in Q1 2025 and troughed at -$730.4 in Q3 2022.
- A 5-year average of -$170.93 and a median of -$9.21 in 2024 frame the typical range for Times Interest Earned.
- The sharpest annual moves came in 2024 and 2025: Times Interest Earned sank 46003.09% in 2024, then surged 230.39% in 2025.
- Over 5 years, Times Interest Earned stood at -$424.75 in 2022, then sank by 55.27% to -$659.51 in 2023, then soared by 100.46% to $3.01 in 2024, then sank by 436.67% to -$10.15 in 2025, then surged by 88.25% to -$1.19 in 2026.
- According to Business Quant data, Times Interest Earned over the past three periods registered -$1.19, -$10.15, and -$1.93 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | PMGC Holdings | 31.22 Mn | 12.43 Mn | 385,691.00 | -6.57 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.19 |
| Dec 31, 2025 | -10.15 |
| Sep 30, 2025 | -1.93 |
| Mar 31, 2025 | 11.63 |
| Dec 31, 2024 | 3.01 |
| Sep 30, 2024 | -1.34 |
| Jun 30, 2024 | -9.50 |
| Mar 31, 2024 | -8.92 |
| Dec 31, 2023 | -659.51 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | -238.90 |
| Mar 31, 2023 | -321.09 |
| Dec 31, 2022 | -424.75 |
| Sep 30, 2022 | -730.40 |